Milestone Pharmaceuticals Inc.
General ticker "MIST" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $114.3M (TTM average)
Milestone Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 36.5%.
Estimated limits based on current volatility of 2.5%: low 2.57$, high 2.70$
Factors to consider:
- Total employees count: 33 as of 2024
- Top business risk factors: Regulatory and compliance, Manufacturing risks, Cybersecurity threats, Operational and conduct risks, Growth challenges
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.32$, 3.34$]
- 2025-12-31 to 2026-12-31 estimated range: [1.14$, 2.94$]
Financial Metrics affecting the MIST estimates:
- Positive: with PPE of -2.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -23.63 <= 0.33
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 2.93 <= 3.41
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Negative: negative Net income
Short-term MIST quotes
Long-term MIST plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $5.00MM | $1.00MM | $0.00MM |
| Operating Expenses | $64.64MM | $62.10MM | $42.10MM |
| Operating Income | $-59.64MM | $-61.10MM | $-42.10MM |
| Non-Operating Income | $1.25MM | $1.41MM | $0.58MM |
| Interest Expense | $0.00MM | $2.55MM | $3.58MM |
| R&D Expense | $39.83MM | $31.05MM | $14.36MM |
| Income(Loss) | $-58.39MM | $-59.69MM | $-41.52MM |
| Profit(Loss)* | $-58.39MM | $-59.69MM | $-41.52MM |
| Stockholders Equity | $66.35MM | $16.77MM | $13.15MM |
| Assets | $74.48MM | $75.23MM | $75.50MM |
| Operating Cash Flow | $-52.47MM | $-46.42MM | $-28.85MM |
| Capital expenditure | $0.27MM | $0.11MM | $0.03MM |
| Investing Cash Flow | $-57.12MM | $4.76MM | $8.28MM |
| Financing Cash Flow | $3.09MM | $47.79MM | $32.12MM |
| Earnings Per Share** | $-1.38 | $-1.39 | $-0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.